TY - JOUR
T1 - Suppression of human melanoma metastasis by introduction of chromosome 6 may be partially due to inhibition of motility, but not to inhibition of invasion
AU - You, Jun
AU - Miele, Mary E.
AU - Dong, Cheng
AU - Welch, Danny R.
PY - 1995/3/17
Y1 - 1995/3/17
N2 - Active cellular motility and invasion play essential roles in metastasis. Introduction of normal, neo-tagged human chromosome 6 (neo6) into highly metastatic human melanoma cell line C8161 results in complete suppression of metastasis in vivo. To understand the mechanism by which metastasis was inhibited in neo6/C8161 hybrids, two in vitro assays, pseudopod protrusion and Membrane Invasion Culture System, were used to measure motility and invasion, respectively. neo6/C8161 hybrids are much less motile although they remained invasive, indicating that a metastasis-suppressor gene(s) on human chromosome 6 may regulate cellular motility, thereby inhibiting metastasis.
AB - Active cellular motility and invasion play essential roles in metastasis. Introduction of normal, neo-tagged human chromosome 6 (neo6) into highly metastatic human melanoma cell line C8161 results in complete suppression of metastasis in vivo. To understand the mechanism by which metastasis was inhibited in neo6/C8161 hybrids, two in vitro assays, pseudopod protrusion and Membrane Invasion Culture System, were used to measure motility and invasion, respectively. neo6/C8161 hybrids are much less motile although they remained invasive, indicating that a metastasis-suppressor gene(s) on human chromosome 6 may regulate cellular motility, thereby inhibiting metastasis.
UR - http://www.scopus.com/inward/record.url?scp=0028899430&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028899430&partnerID=8YFLogxK
U2 - 10.1006/bbrc.1995.1363
DO - 10.1006/bbrc.1995.1363
M3 - Article
C2 - 7695596
AN - SCOPUS:0028899430
SN - 0006-291X
VL - 208
SP - 476
EP - 484
JO - Biochemical and Biophysical Research Communications
JF - Biochemical and Biophysical Research Communications
IS - 2
ER -